Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"27,934 (15,590, 43,179)","50.4% (35.2%, 63.6%)","72.2% (52.0%, 88.4%)","16.7% (10.4%, 30.1%)","48.1% (33.2%, 60.8%)","17.7 (12.3, 22.3)","25.3 (18.2, 30.9)","5.8 (3.7, 10.5)","16.8 (11.6, 21.3)",,,,,
"(p=None, None), q=(None, None), c=0.500)","24,031 (11,787, 40,171)","59.7% (40.2%, 79.4%)","40.5% (25.3%, 57.3%)","9.3% (5.5%, 13.9%)","57.0% (38.0%, 76.5%)","20.9 (14.1, 27.8)","14.2 (8.8, 20.1)","3.3 (1.9, 4.9)","20.0 (13.3, 26.8)","-15.0% (-30.8%, -2.1%)","18.4% (4.1%, 39.9%)","-43.9% (-63.1%, -20.7%)","-40.5% (-71.7%, -5.9%)","18.6% (4.2%, 38.9%)"
"(p=None, None), q=(None, None), c=0.750)","24,058 (11,705, 40,159)","60.0% (40.8%, 80.1%)","39.7% (25.0%, 58.7%)","9.0% (5.4%, 14.2%)","57.6% (38.5%, 77.5%)","21.0 (14.3, 28.0)","13.9 (8.7, 20.5)","3.2 (1.9, 5.0)","20.2 (13.5, 27.1)","-14.9% (-34.1%, -3.6%)","19.1% (6.1%, 39.6%)","-44.9% (-64.4%, -22.1%)","-42.6% (-72.2%, -11.6%)","19.8% (6.4%, 40.8%)"
"(p=None, None), q=(None, None), c=1.000)","24,178 (12,056, 39,795)","60.2% (40.7%, 78.0%)","39.2% (24.7%, 57.5%)","8.7% (5.1%, 13.2%)","57.8% (38.4%, 75.6%)","21.1 (14.3, 27.3)","13.7 (8.7, 20.1)","3.0 (1.8, 4.6)","20.2 (13.4, 26.5)","-14.3% (-33.4%, -2.9%)","19.5% (6.9%, 35.2%)","-45.7% (-64.8%, -27.3%)","-44.6% (-72.8%, -9.6%)","20.3% (7.0%, 36.8%)"
